These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 11593702

  • 1. [Retrospective evaluation of PSA density for selection of biopsy candidates with prostate specific antigen in the gray zone].
    Tochigi T, Kawamura S, Numahata K, Tokuyama S, Kuwahara M, Horaguchi T, Satou S.
    Nihon Hinyokika Gakkai Zasshi; 2001 Sep; 92(6):609-14. PubMed ID: 11593702
    [Abstract] [Full Text] [Related]

  • 2. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.
    Catalona WJ, Richie JP, deKernion JB, Ahmann FR, Ratliff TL, Dalkin BL, Kavoussi LR, MacFarlane MT, Southwick PC.
    J Urol; 1994 Dec; 152(6 Pt 1):2031-6. PubMed ID: 7525994
    [Abstract] [Full Text] [Related]

  • 3. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
    Gohji K, Nomi M, Egawa S, Morisue K, Takenaka A, Okamoto M, Ohori M, Fujii A.
    Cancer; 1997 May 15; 79(10):1969-76. PubMed ID: 9149025
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Cutoff Point Prostate Specific Antigen (PSA) and Prostate Specific Antigen Density (PSAD) in Patients with Suspected Prostate Cancer.
    Daryanto B, Trianto R, Seputra KP, Purnomo AF.
    Med Arch; 2024 May 15; 78(1):12-15. PubMed ID: 38481588
    [Abstract] [Full Text] [Related]

  • 5. [Utility of prostate specific antigen (PSA) density in detecting prostate cancer in men showing gray zone serum PSA levels].
    Kihara T, Ito F, Kobayashi C, Ryoji O, Tokumoto T, Iguchi Y, Maeda Y, Onizuka S, Goya N, Nakazawa H, Toma H.
    Hinyokika Kiyo; 1997 Jan 15; 43(1):13-8. PubMed ID: 9046415
    [Abstract] [Full Text] [Related]

  • 6. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
    Bretton PR, Evans WP, Borden JD, Castellanos RD.
    Cancer; 1994 Dec 01; 74(11):2991-5. PubMed ID: 7525040
    [Abstract] [Full Text] [Related]

  • 7. Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men.
    Sheikh M, Al-Saeed O, Kehinde EO, Sinan T, Anim JT, Ali Y.
    Int Urol Nephrol; 2005 Dec 01; 37(4):721-6. PubMed ID: 16362587
    [Abstract] [Full Text] [Related]

  • 8. The usefulness of prostate-specific antigen (PSA) density in patients with intermediate serum PSA level in a country with low incidence of prostate cancer.
    Yu HJ, Lai MK.
    Urology; 1998 May 01; 51(5A Suppl):125-30. PubMed ID: 9610567
    [Abstract] [Full Text] [Related]

  • 9. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
    Kubota Y, Kamei S, Nakano M, Ehara H, Deguchi T, Tanaka O.
    Int J Urol; 2008 Apr 01; 15(4):322-6; discussion 327. PubMed ID: 18380820
    [Abstract] [Full Text] [Related]

  • 10. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M, Varedi P, Hosseini SJ, Asgari M, Shakiba M.
    Urol J; 2009 Apr 01; 6(3):182-8. PubMed ID: 19711272
    [Abstract] [Full Text] [Related]

  • 11. A higher PSA-density cut-off level in patients with intermediate PSA values for the early detection of prostate cancer.
    Mochtar CA, Rahardjo D, Umbas R.
    Gan To Kagaku Ryoho; 2000 May 01; 27 Suppl 2():514-22. PubMed ID: 10895203
    [Abstract] [Full Text] [Related]

  • 12. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
    Chiang IN, Chang SJ, Pu YS, Huang KH, Yu HJ, Huang CY.
    Urol Int; 2009 May 01; 82(3):270-5. PubMed ID: 19440012
    [Abstract] [Full Text] [Related]

  • 13. [Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml].
    Janane A, Hajji F, Ismail T, Jawad C, Elondo JC, Dakka Y, Ghadouane M, Ameur A, Abbar M, Albouzidi A.
    Actas Urol Esp; 2012 Feb 01; 36(2):93-8. PubMed ID: 22188752
    [Abstract] [Full Text] [Related]

  • 14. Prospective evaluation of prostate specific antigen density and systematic biopsy for detecting prostate cancer in Japanese patients with normal rectal examinations and intermediate prostate specific antigen levels.
    Arai Y, Maeda H, Ishitoya S, Okubo K, Okada T, Aoki Y.
    J Urol; 1997 Sep 01; 158(3 Pt 1):861-4. PubMed ID: 9258099
    [Abstract] [Full Text] [Related]

  • 15. Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?
    Ohori M, Dunn JK, Scardino PT.
    Urology; 1995 Nov 01; 46(5):666-71. PubMed ID: 7495118
    [Abstract] [Full Text] [Related]

  • 16. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
    Rahardjo D, Kamil ST, Pakasi LS.
    Gan To Kagaku Ryoho; 2000 May 01; 27 Suppl 2():563-70. PubMed ID: 10895211
    [Abstract] [Full Text] [Related]

  • 17. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H, Kajita Y, Shimizu Y, Yamauchi T.
    Hinyokika Kiyo; 2001 Mar 01; 47(3):169-74. PubMed ID: 11329957
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes.
    MacAskill F, Lee SM, Eldred-Evans D, Wulaningsih W, Popert R, Wolfe K, Van Hemelrijck M, Rottenberg G, Liyanage SH, Acher P.
    Int Urol Nephrol; 2017 Aug 01; 49(8):1335-1342. PubMed ID: 28477301
    [Abstract] [Full Text] [Related]

  • 19. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL.
    Castro HAS, Iared W, Santos JEM, Solha RS, Shigueoka DC, Ajzen SA.
    Int Braz J Urol; 2018 Aug 01; 44(4):709-716. PubMed ID: 29697929
    [Abstract] [Full Text] [Related]

  • 20. The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men.
    Teoh JY, Yuen SK, Tsu JH, Wong CK, Ho BS, Ng AT, Ma WK, Ho KL, Yiu MK.
    Asian J Androl; 2017 Aug 01; 19(1):113-116. PubMed ID: 26620456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.